Trials / Completed
CompletedNCT01884337
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
A Phase IV, Open-Label, Multi-center Study to Evaluate the Safety of Apixaban in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 557 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this protocol is to evaluate the safety of Apixaban in prophylaxis of Venous Thromboembolism (VTE) in Indian patients undergoing elective total knee or hip replacement
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apixaban |
Timeline
- Start date
- 2015-03-24
- Primary completion
- 2018-06-04
- Completion
- 2018-06-04
- First posted
- 2013-06-24
- Last updated
- 2019-11-29
- Results posted
- 2019-09-09
Locations
20 sites across 1 country: India
Source: ClinicalTrials.gov record NCT01884337. Inclusion in this directory is not an endorsement.